Literature DB >> 30500980

Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.

Qiyu Lu1, Xudong Ma1, Yijun Li1, Wanhong Song2, Lingshu Zhang1, Yixiong Shu1, Baosheng Wan1.   

Abstract

BACKGROUND: Expression of forkhead box (FOX) superfamily members has been shown to be decreased in cancer, which was linked to poor prognosis of patients. The aim of this study was to investigate the expression of a new FOX superfamily member, FOXS1, in gastric cancer, and the influence of FOXS1 overexpression on the tumorigenesis of gastric cancer cells. The underlying molecular mechanism was also investigated.
MATERIALS AND METHODS: FOXS1 expression levels were firstly measured in 15 paired gastric cancer and peritumor tissue using quantitative polymerase chain reaction or immunohistochemistry. Secondly, FOXS1 overexpression models were established in two gastric cancer cell lines (SNU-216 and AGS) and FOXS1 knockdown model was established in SNU-638 gastric cancer cell line. Markers for cell proliferation, metastasis, cell cycle status, and wnt/β-catenin pathway were evaluated. Influence of FOXS1 overexpression on tumorigenesis was further evaluated in xenograft model.
RESULTS: Expression of FOXS1 was significantly decreased in gastric cancer tissue in both messenger RNA and protein levels, compared with peritumor tissue. Our results showed that compared to cell lines transfected with negative control, gastric cancer cell lines with FOXS1 overexpression showed suppressed cell proliferation, metastasis, and increased ratio of G0/G1 phase. Xenograft model also showed suppressed tumor growth in FOXS1 overexpression group. Epithelial-mesenchymal transition was also inhibited when FOXS1 was overexpressed, which was indicated by an increase of E-cadherin expression and decrease in vimentin expression. Further investigation showed that expression of β-catenin was decreased, together with decreased expression in downstream signaling factors, c-Myc and cyclin-D1 in FOXS1 overexpression cell lines. On the other hand, knockdown of FOXS1 showed opposite trends in the changes of those markers for cell proliferation, metastasis, cell cycle status, and wnt/β-catenin pathway, compared with FOXS1 overexpression.
CONCLUSION: In conclusion, the present study showed that FOXS1 expression is downregulated in most GC cases in our cohort, and this loss of expression may promote cell proliferation and metastasis through upregulation of wnt/β-catenin pathway.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  FOXS1; forkhead box; gastric cancer; tumorigenesis; wnt/β-catenin pathway

Mesh:

Substances:

Year:  2018        PMID: 30500980     DOI: 10.1002/jcb.26821

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma.

Authors:  Dengliang Lei; Gangli Hu; Yue Chen; Tuantuan Hao; Yu Gao; Fang Luo
Journal:  Onco Targets Ther       Date:  2020-11-17       Impact factor: 4.147

2.  TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer.

Authors:  Kevin Bévant; Matthis Desoteux; Gaëlle Angenard; Raphaël Pineau; Stefano Caruso; Corentin Louis; Panagiotis Papoutsoglou; Laurent Sulpice; David Gilot; Jessica Zucman-Rossi; Cédric Coulouarn
Journal:  Hepatol Commun       Date:  2021-11-26

3.  Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy.

Authors:  Yunqiang Liu; Mengjun Tu; Lingling Wang
Journal:  Int J Gen Med       Date:  2022-02-25

4.  FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer.

Authors:  Junfeng Qiu; Mingzhou Li; Cailin Su; Yihao Liang; Ruizhang Ou; Xiaoning Chen; Chengmei Huang; Yaxin Zhang; Yaping Ye; Wenting Liao; Chao Zhang
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

Review 5.  FOXO transcription factor family in cancer and metastasis.

Authors:  Yannasittha Jiramongkol; Eric W-F Lam
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.